[Skip to Content]

Claim CME

Dermatology

Dermatology and COVID-19

Educational Objective
To understand how dermatology can assist in detecting and managing COVID-19

1 Credit CME

JAMA

Published Online: September 22/29, 2020

Viewpoint

Article Information and Disclosures

Kanade Shinkai, MD, PhD^1,2;

Anna L. Bruckner, MD, MSCS^3,4

Author Affiliations

¹Department of Dermatology, University of California, San Francisco
²Editor, JAMA Dermatology
³University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora
⁴Deputy Editor, JAMA Dermatology

Read article on JAMA Network

Viewpoint

Neurology and COVID-19

S. Andrew Josephson, MD; Hooman Kamel, MD
Viewpoint

Psychiatry and COVID-19

Dost Öngür, MD, PhD; Roy Perlis, MD, MSc; Donald Goff, MD
Viewpoint

Pediatrics and COVID-19

Dimitri A. Christakis, MD, MPH
Viewpoint

Cardiology and COVID-19

Robert O. Bonow, MD, MS; Patrick T. O’Gara, MD; Clyde W. Yancy, MD, MSc
Viewpoint

Internal Medicine and COVID-19

Rita F. Redberg, MD, MSc; Mitchell Katz, MD; Robert Steinbrook, MD
Viewpoint

Surgery and COVID-19

Melina R. Kibbe, MD
Viewpoint

JAMA Network Open and COVID-19

Frederick P. Rivara, MD, MPH; Stephan D. Fihn, MD, MPH; Eli N. Perencevich, MD, MS
Viewpoint

Otolaryngology and COVID-19

Jay F. Piccirillo, MD
Viewpoint

Nephrology and COVID-19

Wolfgang C. Winkelmayer, MD, MPH, ScD; Pascale Khairallah, MD; David M. Charytan, MD
Viewpoint

Oncology and COVID-19

Mary L. Disis, MD
Viewpoint

Ophthalmology and COVID-19

Neil M. Bressler, MD
Viewpoint

Health Policy and COVID-19

John Z. Ayanian, MD, MPP

Read Article Claim CME

Even early in the coronavirus disease 2019 (COVID-19) pandemic, it was clear that dermatologists had an important role in the management of patients. Although initial case series rarely documented skin changes, possibly due to the inability to perform a complete skin examination, subsequent research has suggested significantly higher rates of skin involvement.¹ The true prevalence of skin findings, the uncertainty of whether these represented direct infection or were associated with systemic illness (eg, reactive or due to medications), and how best to manage them were among the many questions challenging the evolving understanding of these cutaneous manifestations. This has been an important opportunity for dermatologists to learn and contribute.² What are the current priorities in dermatology research and clinical care as the COVID-19 pandemic progresses?

Claim CME

Sign in to take quiz and track your certificates

Buy This Activity

Article Information

Corresponding Author: Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 (kanade.shinkai@jamanetwork.org).

Conflict of Interest Disclosures: None reported.

References

Galván Casas C , Català A , Carretero Hernández G , et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163 PubMed Google Scholar Crossref

Madigan LM , Micheletti RG , Shinkai K . How dermatologists can learn and contribute at the leading edge of the COVID-19 global pandemic. JAMA Dermatol. 2020;156(7):733-734. doi:10.1001/jamadermatol.2020.1438 PubMed Google Scholar Crossref

Lester JC , Lia JL , Zhang L , Okoye GA , Linos E . Absence of images of skin of colour in publications of COVID-19 skin manifestations. Br J Derm. Published online May 29, 2020. doi:10.1111/bjd.19258 Google Scholar

Droesch C , Hoang M , DeSancho M , Lee E-J , Magro C , Harp J . Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19. JAMA Dermatol. Published online August 5, 2020. doi:10.1001/jamadermatol.2020.2800 Google Scholar

Whittaker E , Bamford A , Kenny J , et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259-269. doi:10.1001/jama.2020.10369 PubMed Google Scholar Crossref

Roca-Ginés J , Torres-Navarro I , Sánchez-Arráez J , et al. Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic. JAMA Dermatol. Published online June 25, 2020. doi:10.1001/jamadermatol.2020.2340 PubMed Google Scholar

Barbieri JS , Frieden IJ , Nagler AR . Isotretinoin, patient saety, and patient-centered care: time to reform iPledge. JAMA Dermatol. 2020;156(1):21-22. doi:10.1001/jamadermatol.2019.3270 Google Scholar Crossref

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
1.00 CME points in the American Board of Surgery’s (ABS) Continuing Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.